| Efficacy analysis population (n = 1629) | |||
| Observed period | Number of patients | Mean insulin glargine dosage (U/day) | |
| Baseline | 1627 | 6.3 | |
| 4 week | 1612 | 7.6 | |
| 8 week | 1570 | 8.5 | |
| 12 week | 1534 | 9.0 | |
| 16 week | 1489 | 9.4 | |
| 20 week | 1445 | 9.8 | |
| 24 week | 1419 | 10.1 | |
| LOCFa) | 1627 | 9.8 | |